Risk Mitigation Strategy for Concizumab Clinical Trials after Pause Due to Non-Fatal Thrombotic Events
Seremetis, Stephanie Valer, Cepo, Katarina, Skovgaard Rasmussen, Josephine, Høyer Rose, Trine, Tamer, Søren, Porstmann, Thomas, Haaning, Jesper
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Characterisation of Population Pharmacokinetics and Endogenous Follicle-Stimulating Hormone (FSH) Levels After Multiple Dosing of a Recombinant Human FSH (FE 999049) in Healthy Women
Rose, Trine Høyer, Röshammar, Daniel, Erichsen, Lars, Grundemar, Lars, Ottesen, Johnny T.
Published in Drugs in R&D (01.06.2016)
Published in Drugs in R&D (01.06.2016)
Get full text
Journal Article
Population Pharmacokinetic Modelling of FE 999049, a Recombinant Human Follicle-Stimulating Hormone, in Healthy Women After Single Ascending Doses
Rose, Trine Høyer, Röshammar, Daniel, Erichsen, Lars, Grundemar, Lars, Ottesen, Johnny T.
Published in Drugs in R&D (01.06.2016)
Published in Drugs in R&D (01.06.2016)
Get full text
Journal Article
A Population Pharmacokinetic Model for Concizumab Based on Phase 1 and Phase 2 Trial Data
Høyer Rose, Trine, Hollensen, Christian, Agersø, Henrik, Viig Overgaard, Rune
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article